%4d%6f%62%69%6c%65%20%43%6c%69%6e%69%63%20%4d%6f%64%75%6c%65
-
MCM Utilized at Residential Treatment Center in Gyeonggi
The Mobile Clinic Module (MCM) developed by the KAIST Action for Respiratory Epidemics was installed at special residential treatment center in Gyeonggi Province on September 13.
The MCM is an isolate negative pressure unit fitted with high-quality medical equipment, developed by Professor Taek-Jin Nam of the Department of Industrial Design under the KAIST New Deal R&D Initiative. This is also a part of the Korean Disease Control Package Development Project from last July.
In January, a ward with four beds for critical care was installed at the Korea Institute for Radiological & Medical Sciences in Seoul for a trial operation, and two mild cases were treated there. It was also implemented as an isolated negative pressure unit in the Daejeon Konyang University Hospital emergency room in June, and has treated 138 cases since.
The special residential treatment center installed in the Gyeonggi Provincial Academy gymnasium, which consists of 28 beds in 14 rooms (double occupancy) and a multipurpose room (for X-rays and treatment), is to remain open through October 10. Unlike existing treatment centers that have quarantined COVID-19 patients for two weeks, the Gyeonggi MCM will act as a self-treatment-associated short-term treatment center. While in self-treatment, patients showing symptoms requiring special attention will be moved to the MCM, followed by short-term hospitalization of 1-3 days for observation before further measures are taken.
Patients can be treated using the MCM’s own treatment capacities, including in-person and oxygen treatment, X-rays, and IVs. There are individual bathrooms in each room, and the pressure, ventilation, and the automatic opening and closing of the entrance can be centrally monitored and controlled. Patients showing symptoms during treatment will be moved to a specially designated hospital for critical care, and will return to the self-treatment center if no further abnormalities are reported.
The Gyeonggi Provincial Medical Center’s Ansung Hospital will take charge of operating the special treatment center. Each day, one or two doctors, three nurses, two nursing assistants, one administrative staff member, two or three disinfection specialists, and a medical imaging engineer will work in three shifts. There will also be about 20 additional specially designated staff members including KAIST researchers, firefighters, and police officers.
The MCM was internationally recognized as an excellent medical facility not only for its functionality, economic feasibility, and utility, but also for its unique design and aesthetics. It received two Best of Best awards at the Red Dot Award in product design and Communication Design in user interface.
By running this special treatment center, KAIST will conduct research on how to build an optimized model for efficient negative pressure medical units. This research is expected to lead to advances in waste water treatment systems, mobile bathrooms optimized for infectious cases, and MCM user interfaces for electronic devices, etc.
Professor Taek-Jin Nam, the general director of the project and design, said “if there is a gymnasium available, we can convert it into a special treatment center fitted with a waste water treatment system, and pressure equipment in two weeks even without additional infrastructure.”
The head of the KAIST New Deal R&D Initiative Choongsik Bae said, “our MCM research started in July of last year, and in just over a year, it has become a successful and innovative case that has undergone trials and become commercialized in a short period of time.” He added, “In response to COVID-19, KAIST is conducting research and empirical studies, not just in relation to the MCM, but in other areas of disease control as well.”
Based on the excellent disease control technologies developed by KAIST research teams, the KAIST Action for Respiratory Epidemics is conducting technology transfers and industrialization, and is developing a Korean disease control package model
2021.09.15 View 16642 -
Repurposed Drugs Present New Strategy for Treating COVID-19
Virtual screening of 6,218 drugs and cell-based assays identifies best therapeutic medication candidates
A joint research group from KAIST and Institut Pasteur Korea has identified repurposed drugs for COVID-19 treatment through virtual screening and cell-based assays. The research team suggested the strategy for virtual screening with greatly reduced false positives by incorporating pre-docking filtering based on shape similarity and post-docking filtering based on interaction similarity. This strategy will help develop therapeutic medications for COVID-19 and other antiviral diseases more rapidly. This study was reported at the Proceedings of the National Academy of Sciences of the United States of America (PNAS).
Researchers screened 6,218 drugs from a collection of FDA-approved drugs or those under clinical trial and identified 38 potential repurposed drugs for COVID-19 with this strategy. Among them, seven compounds inhibited SARS-CoV-2 replication in Vero cells. Three of these drugs, emodin, omipalisib, and tipifarnib, showed anti-SARS-CoV-2 activity in human lung cells, Calu-3.
Drug repurposing is a practical strategy for developing antiviral drugs in a short period of time, especially during a global pandemic. In many instances, drug repurposing starts with the virtual screening of approved drugs. However, the actual hit rate of virtual screening is low and most of the predicted drug candidates are false positives.
The research group developed effective filtering algorithms before and after the docking simulations to improve the hit rates. In the pre-docking filtering process, compounds with similar shapes to the known active compounds for each target protein were selected and used for docking simulations. In the post-docking filtering process, the chemicals identified through their docking simulations were evaluated considering the docking energy and the similarity of the protein-ligand interactions with the known active compounds.
The experimental results showed that the virtual screening strategy reached a high hit rate of 18.4%, leading to the identification of seven potential drugs out of the 38 drugs initially selected.
“We plan to conduct further preclinical trials for optimizing drug concentrations as one of the three candidates didn’t resolve the toxicity issues in preclinical trials,” said Woo Dae Jang, one of the researchers from KAIST.
“The most important part of this research is that we developed a platform technology that can rapidly identify novel compounds for COVID-19 treatment. If we use this technology, we will be able to quickly respond to new infectious diseases as well as variants of the coronavirus,” said Distinguished Professor Sang Yup Lee.
This work was supported by the KAIST Mobile Clinic Module Project funded by the Ministry of Science and ICT (MSIT) and the National Research Foundation of Korea (NRF). The National Culture Collection for Pathogens in Korea provided the SARS-CoV-2 (NCCP43326).
-PublicationWoo Dae Jang, Sangeun Jeon, Seungtaek Kim, and Sang Yup Lee. Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay. Proc. Natl. Acad. Sci. U.S.A. (https://doi/org/10.1073/pnas.2024302118)
-ProfileDistinguished Professor Sang Yup LeeMetabolic &Biomolecular Engineering National Research Laboratoryhttp://mbel.kaist.ac.kr
Department of Chemical and Biomolecular EngineeringKAIST
2021.07.08 View 20440 -
Research Day Highlights the Most Impactful Technologies of the Year
Technology Converting Full HD Image to 4-Times Higher UHD Via Deep Learning Cited as the Research of the Year
The technology converting a full HD image into a four-times higher UHD image in real time via AI deep learning was recognized as the Research of the Year. Professor Munchurl Kim from the School of Electrical Engineering who developed the technology won the Research of the Year Grand Prize during the 2021 KAIST Research Day ceremony on May 25. Professor Kim was lauded for conducting creative research on machine learning and deep learning-based image processing.
KAIST’s Research Day recognizes the most notable research outcomes of the year, while creating opportunities for researchers to immerse themselves into interdisciplinary research projects with their peers. The ceremony was broadcast online due to Covid-19 and announced the Ten R&D Achievement of the Year that are expected to make a significant impact.
To celebrate the award, Professor Kim gave a lecture on “Computational Imaging through Deep Learning for the Acquisition of High-Quality Images.” Focusing on the fact that advancements in artificial intelligence technology can show superior performance when used to convert low-quality videos to higher quality, he introduced some of the AI technologies that are currently being applied in the field of image restoration and quality improvement.
Professors Eui-Cheol Shin from the Graduate School of Medical Science and Engineering and In-Cheol Park from the School of Electrical Engineering each received Research Awards, and Professor Junyong Noh from the Graduate School of Culture Technology was selected for the Innovation Award. Professors Dong Ki Yoon from the Department of Chemistry and Hyungki Kim from the Department of Mechanical Engineering were awarded the Interdisciplinary Award as a team for their joint research.
Meanwhile, out of KAIST’s ten most notable R&D achievements, those from the field of natural and biological sciences included research on rare earth element-platinum nanoparticle catalysts by Professor Ryong Ryoo from the Department of Chemistry, real-time observations of the locational changes in all of the atoms in a molecule by Professor Hyotcherl Ihee from the Department of Chemistry, and an investigation on memory retention mechanisms after synapse removal from an astrocyte by Professor Won-Suk Chung from the Department of Biological Sciences.
Awardees from the engineering field were a wearable robot for paraplegics with the world’s best functionality and walking speed by Professor Kyoungchul Kong from the Department of Mechanical Engineering, fair machine learning by Professor Changho Suh from the School of Electrical Engineering, and a generative adversarial networks processing unit (GANPU), an AI semiconductor that can learn from even mobiles by processing multiple and deep networks by Professor Hoi-Jun Yoo from the School of Electrical Engineering.
Others selected as part of the ten research studies were the development of epigenetic reprogramming technology in tumour by Professor Pilnam Kim from the Department of Bio and Brain Engineering, the development of an original technology for reverse cell aging by Professor Kwang-Hyun Cho from the Department of Bio and Brain Engineering, a heterogeneous metal element catalyst for atmospheric purification by Professor Hyunjoo Lee from the Department of Chemical and Biomolecular Engineering, and the Mobile Clinic Module (MCM): a negative pressure ward for epidemic hospitals by Professor Taek-jin Nam (reported at the Wall Street Journal) from the Department of Industrial Design.
2021.05.31 View 20063 -
Ushering in a New Era at the 50th Innoversary Ceremony
President Moon Jae-In declares KAIST the future of Korea
KAIST reaffirmed its goal of becoming an institute that can serve the world for the next century, marking its 50th anniversary on February 16. The KAIST community and distinguished guests gathered online during the official ceremony to commemorate KAIST’s anniversary and envisioned ways to serve the world, a major shift from its founding mission focusing on national growth.
The ceremony celebrated the legacy of KAIST, which has become a trailblazer by fostering the most competent scientists and engineers and making breakthroughs which led to the nation becoming a global high-tech leader.
President Moon Jae-In applauded KAIST as “the future of Korea” in his online congratulatory message, saying that “KAIST has made us feel proud when the nation stays ahead in science and technology. The dream of KAIST has been the dream of Korea. The passion of KAIST has been the passion of Korea. KAIST is the future of Korea.”
“KAIST has overcome challenges and created innovations for advancing the nation, from the first internet network to launching our first satellite in the early 80s to the Mobile Clinic Module (MCM), a negative pressure ward module in response to COVID-19. Whenever the nation faced a challenge, KAIST was there.”
President Moon also asked KAIST researchers to find sustainable ways to balance nature and humanity in this time of climate change and the Fourth Industrial Revolution.
Executive Chairman of the World Economic Forum Dr.Klaus Schwab also congratulated, saying "KAIST is a leader in ensuring social inclusion. Founded with the support of USAID, today it is paying it forward and sharing the same support through the Kenya-KAIST project."
The ceremony first brought Dr. KunMo Chung to the stage, the man who proposed the idea of founding the first advanced science and technology institute in Korea. His proposal to the then administrator of USAID John Hannah resulted in the Korean government meriting a 6 million USD loan for to start KAIST. He was the only Korean member of the USAID feasibility study team led by Dr. Frederick Terman, the former vice president of Stanford University. Dr. Chung wrote the Terman Report, which gave a green light to the establishment of KAIST in Korea in 1970.
Dr. Chung said the nation’s strong desire to escape from poverty through the advancement of science and technology was thoroughly realized by KAIST. “The Terman Report’s vision was perfectly realized. Now it’s time to envision the next dream of KAIST for another century.”
President Sung-Chul Shin said in his anniversary speech that KAIST has now transformed into a university that will serve the all of humanity by advancing science and technology while fostering new talents best fit for the new global environment. President Shin said that to fulfill KAIST’s second dream, the university will drive innovation in the five major areas of education, research, technology commercialization, globalization, and future strategy, under the C3 spirit of a Challenging spirit, Creativity, and Caring minds.
“In the next 50 years, KAIST hopes to fulfill the 10-10-10 Dream, that is, to have 10 Singularity Professors who have produced world-class achievements, 10 Decacorn startups valued at 10 trillion won, and global campuses in 10 countries.”
Then, four young KAIST professors who are conducting research in the flagship fields of mobility, new materials, post-AI, and bio-medicine presented their research vision and gave speeches. Professor Hae-Won Park from the Department of Mechanical Engineering and Professor Jihyeon Yeom from the Department of Materials Science and Engineering said the advent of new mobility combined with robotics and new nano-materials scaled down into spintronics, ‘KAISTronic materials’, will provide new momentum for the industry and the wellbeing of humanity. Professor Kijung Shin from the Graduate School of AI spoke on the new future transformed by quantum computers. Professor Young Seok Ju from the Graduate School of Medical Science and Engineering predicted a future in which cancer will no longer be a terminal disease and digital cells and the digitization of bio-medicine will significantly improve our quality of life. He said the combination of anti-aging and reverse aging studies will make a difference in our lives.
After the official ceremony, KAIST’s administrative leadership including President Shin and Dr. Kun-Mo Chung attended a ceremony to dedicate the sky lounge at the Academic Cultural Complex as the John Hannah Hall. Terman Hall, located in the Creative Learning Building, was dedicated in 2004 in honor of Dr. Frederick Terman.
2021.02.17 View 16228 -
KAIST Mobile Clinic Module to Fill Negative Pressure Ward Shortage
Efficient versatile ready-for-rapid building system of MCM will serve as both a triage unit and bridge center in emergency medical situations
A team from KAIST has developed a low-cost and ready-for-rapid-production negative pressure room called a Mobile Clinic Module (MCM). The MCM is expandable, moveable, and easy to store through a combination of negative pressure frames, air tents, and multi-function panels.
The MCM expects to quickly meet the high demand for negative pressure beds in the nation and eventually many other countries where the third wave of COVID-19 is raging. The module is now ready to be rolled out after a three-week test period at the Korea Cancer Center Hospital.
Professor Tek-Jin Nam’s team swung into action, rapidly working together with researchers, engineers with expertise in mechanical design, and a team of clinical doctors to complete the MCM as one of KAIST’s New Deal R&D initiatives launched last July.
Professor Nam cites ‘expandability’ as the key feature of the MCM. Eventually, it will serve as both a triage unit and bridge center in emergency medical situations.
“The module is a very efficient and versatile unit building system. It takes approximately two hours to build the basic MCM unit, which comprises four negative pressure bed rooms, nurse’s station, locker room, and treatment room. We believe this will significantly contribute to relieving the drastic need for negative pressure beds and provide a place for monitoring patients with moderate symptoms,” said Professor Nam.
“It will also be helpful for managing less-severe patients who need to be monitored daily in quarantined rooms or as bridge stations where on-site medical staff can provide treatment and daily monitoring before hospitalization. These wards can be efficiently deployed either inside or outside existing hospitals.”
The research team specially designed the negative pressure frame to ensure safety level A for the negative pressure room, which is made of a multi-function panel wall and roofed with an air tent. The multi-function panels can hold medical appliances such as ventilators, oxygen and bio-signal monitors.
Positive air pressure devices supply fresh air from outside the tent. An air pump and controller maintain air beam pressure, while filtering exhausted air. An internal air information monitoring system efficiently controls room air pressure and purifies the air.
While a conventional negative pressure bed is reported to cost approximately 3.5 billion KRW (50 billion won for a ward), this module is estimated to cost 0.75 billion won each (10 billion won for a ward), cutting the costs by approximately 80%.
The MCM is designed to be easily transported and relocated due to its volume, weight, and maintainability. This module requires only one-fourth of the volume of existing wards and takes up approximately 40% of their weight. The unit can be transported in a 40-foot container truck.
“We believe this will significantly contribute to relieving the drastic need for negative pressure beds and provide a place for monitoring patients with moderate symptoms. We look forward to the MCM upgrading epidemic management resources around the world.”
Professor Nam’s team is also developing antiviral solutions and devices such as protective gear, sterilizers, and test kits under the KAIST New Deal R&D Initiative that was launched to promptly and proactively respond to the epidemic. More than 45 faculty members and researchers at KAIST are collaborating with industry and clinical hospitals to develop the antiviral technology that will improve preventive measures, diagnoses, and treatment.
2021.01.07 View 15754